Laya Blokzijl

581 total citations
8 papers, 440 citations indexed

About

Laya Blokzijl is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Laya Blokzijl has authored 8 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Hematology. Recurrent topics in Laya Blokzijl's work include Systemic Lupus Erythematosus Research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Platelet Disorders and Treatments (2 papers). Laya Blokzijl is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Platelet Disorders and Treatments (2 papers). Laya Blokzijl collaborates with scholars based in Netherlands. Laya Blokzijl's co-authors include Philip G. de Groot, P Hasselaar, Ronald H. W. M. Derksen, R. H. W. M. Derksen, F H Gmelig Meyling, Jan J. Sixma, P G de Groot, Bonno N. Bouma, R. H. W. M. Derksen and H K Nieuwenhuis and has published in prestigious journals such as Annals of the Rheumatic Diseases, Thrombosis and Haemostasis and PubMed.

In The Last Decade

Laya Blokzijl

8 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laya Blokzijl Netherlands 7 377 222 89 69 56 8 440
Harris En United States 8 424 1.1× 143 0.6× 93 1.0× 85 1.2× 23 0.4× 10 460
Derksen Rh Netherlands 9 551 1.5× 348 1.6× 142 1.6× 129 1.9× 51 0.9× 14 663
Gharavi Ae United States 11 503 1.3× 164 0.7× 115 1.3× 116 1.7× 24 0.4× 16 580
B Sredni Israel 7 312 0.8× 146 0.7× 77 0.9× 138 2.0× 36 0.6× 8 418
SS Pierangeli United States 9 335 0.9× 227 1.0× 67 0.8× 83 1.2× 27 0.5× 11 414
Barbara Montaruli Italy 13 313 0.8× 256 1.2× 69 0.8× 57 0.8× 24 0.4× 32 444
Linda K Barna United States 7 288 0.8× 266 1.2× 101 1.1× 57 0.8× 12 0.2× 9 417
L Spatola Italy 10 544 1.4× 230 1.0× 182 2.0× 178 2.6× 105 1.9× 12 603
Graciela S Cerrato Argentina 8 222 0.6× 172 0.8× 67 0.8× 51 0.7× 24 0.4× 11 303
G Thibaut France 4 267 0.7× 165 0.7× 47 0.5× 56 0.8× 11 0.2× 15 348

Countries citing papers authored by Laya Blokzijl

Since Specialization
Citations

This map shows the geographic impact of Laya Blokzijl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laya Blokzijl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laya Blokzijl more than expected).

Fields of papers citing papers by Laya Blokzijl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laya Blokzijl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laya Blokzijl. The network helps show where Laya Blokzijl may publish in the future.

Co-authorship network of co-authors of Laya Blokzijl

This figure shows the co-authorship network connecting the top 25 collaborators of Laya Blokzijl. A scholar is included among the top collaborators of Laya Blokzijl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laya Blokzijl. Laya Blokzijl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Derksen, Ronald H. W. M., et al.. (1992). Antiphospholipid Antibody Positive Sera Enhance Endothelial Cell Procoagulant Activity – Studies in a Thrombosis Model. Thrombosis and Haemostasis. 68(3). 278–284. 59 indexed citations
2.
Hasselaar, P, R. H. W. M. Derksen, Laya Blokzijl, et al.. (1990). Heat treatment of serum and plasma induces false positive results in the antiphospholipid antibody ELISA.. PubMed. 17(2). 186–91. 30 indexed citations
3.
Hasselaar, P, Ronald H. W. M. Derksen, Laya Blokzijl, & Philip G. de Groot. (1990). Crossreactivity of Antibodies Directed against Cardiolipin, DNA, Endothelial Cells and Blood Platelets. Thrombosis and Haemostasis. 63(2). 169–173. 70 indexed citations
5.
Hasselaar, P, R. H. W. M. Derksen, Laya Blokzijl, et al.. (1989). Risk factors for thrombosis in lupus patients.. Annals of the Rheumatic Diseases. 48(11). 933–940. 47 indexed citations
6.
Derksen, R. H. W. M., P Hasselaar, Laya Blokzijl, F H Gmelig Meyling, & Philip G. de Groot. (1988). Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.. Annals of the Rheumatic Diseases. 47(5). 364–371. 115 indexed citations
7.
Hasselaar, P, Ronald H. W. M. Derksen, Laya Blokzijl, & Philip G. de Groot. (1988). Thrombosis Associated with Antiphospholipid Antibodies Cannot Be Explained by Effects on Endothelial and Platelet Prostanoid Synthesis. Thrombosis and Haemostasis. 59(1). 80–85. 63 indexed citations
8.
Hasselaar, P, et al.. (1987). THE EFFECT OF ANTICARDIOLIPIN POSITIVE SERA FROM SLE PATIENTS ON PLATELET AND ENDOTHELIAL PROSTANOID SYNTHESIS. Thrombosis and Haemostasis. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026